Haisco Pharmaceutical partners with ARCH Venture Partners and Population Health in new China-focused deal
read at Endpoints ↗DealPositive
Haisco Pharmaceutical, a China-based drugmaker, has continued its active summer dealmaking by striking a new partnership.
The partnership brings together ARCH Venture Partners, a venture capital firm led by Bob Nelsen, and Population Health Partners, headed by Clive Meanwell.
The three entities aim to collaborate on biotech initiatives in China, reflecting a broader trend of foreign investors seeking opportunities in the Chinese market.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “ARCH and Population Health join China blitz with Haisco deal”
read at Endpoints ↗95 words · retrieved Aug 25
comments(0)
5-min edit window · permanent after that